Investor Presentaiton slide image

Investor Presentaiton

In order to scale up zinc/ORS, several barriers need to be overcome Affordable Supply Distribution Provider demand Caregiver demand Retail prices of the zinc/ORS products are high, due to high ex-factory prices and highly fragmented distribution chain that accumulate high, variable mark- ups. Most products are therefore more expensive in rural markets than urban. Very few pharmaceutical products reach rural markets because distribution systems are fragmented and inefficient, promotional activities in rural markets cost more money and reach fewer people, and rural markets are perceived to have lower consumer spending profiles. Public sector: Public health centers struggle to provide quality health services, due to limited availability of stock and training. Private sector: Private drug sellers typically untrained, leading to inconsistent and poor treatment of diarrheal diseases. Consumers' preferences play a strong role in product selection when attending PPMVs, often leading to inappropriate treatment. Diarrhea perceived as normal for young children in Nigeria. Caregivers cite teething as a major cause of diarrhea. Alternative treatment regimens are often preferred, and treatment itself is frequently unaffordable. Scale Due to anemic demand, suppliers have limited incentive to invest in distribution and promotion of zinc and ORS, resulting in reduced competition, poor product access and high consumer prices. | 9
View entire presentation